There are 6 result(s) found based on your search criteria

1-6 from 6 result(s)

New ESVAC report: antibiotic use continues to decline in animal husbandry in Europe.

The European Medicines Agency (EMA) published the tenth ESVAC report (European Surveillance of Veterinary Antimicrobial Consumption) about the sale of antibacterial agents for veterinary use in 2018. Further efforts remain necessary, in Belgium as well.

New downward trend in the consumption of antibiotics in animal husbandry in Belgium

The new BelVet-SAC report which contains an overview of the use of antibiotics in veterinary medicine is available. The 2019 results confirm the trends of previous years with consumption down 7.8% for mg of active substance/kg of biomass compared to last year. Compared to the 2011 reference year, the use of antibiotics in veterinary medicine has decreased by 40.3%.

Webinar on the use of antibiotics and antibiotic resistance in animals: 2019 results, what is the outlook after 2020?

On Monday 22 June 2020 AMCRA, FASFC, FAMHP and FPS Public Health will host a webinar presenting the latest results on the use of antibiotics in animals and the fight against antimicrobial resistance.

Coronavirus: the FAMHP continues to supply essential medicinal products for intensive care and provides hospitals with daily updates

The FAMHP is addressing the concerns of healthcare professionals. To cope with the difficulties in supplying medicinal products, FAMHP experts are in constant contact with hospital pharmacies and are working tirelessly to find solutions. There is currently no shortage of medicinal products preventing the treatment of COVID-19 patients in Belgium.

COVID-19: electronic files submission

Following the recommendations of the Belgian National Security Council regarding the coronavirus epidemic, the FAMHP encourages employees to work more from home. Therefore, we ask all our partners to submit their files to us electronically as much as possible.

Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation

Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.

1-6 from 6 result(s)